Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. Plasma fractionation process is used in treating protein deficiency in healthcare applications. It is also used in production of packaging material for industrial applications. The removal or inactivation of viruses and prions is a prime function of plasma fractionation.
Increasing use of immunoglobulin in therapeutic areas and prevalence of emphysema & AATD are factors fueling the growth of the world plasma fractionation market. However, high cost, limited reimbursement, and stringent government regulations obstruct growth of the market. On the other hand, increasing number of hemophilic patients are creating opportunities for growth.
Get Sample Report of Plasma Fractionation Market @http://www.intenseresearch.com/market-analysis/world-plasma-fractionation-market-opportunities-and-forecasts-2014.html#request-sample
The world plasma fractionation market is segmented based on product, application, end user, and geography. On the basis of products, the market is classified into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further classified into subcutaneous immunoglobulin (SCIg), intravenous immunoglobulin (IVIg), and others. Coagulation factor concentrates are divided into factor VIII, factor IX, factor XIII, Von Willebrand factor, prothrombin coagulation concentrates, and fibrinogen concentrates. Applications included in the report are neurology, hematology, immunology, critical care, and others. End users covered in the report are hospitals and clinical research laboratories. Geographically, the market is divided into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).
The prominent companies operating in the market are Grifols SA, Baxter International Inc., CSL Ltd., Bio Product Laboratory, Octapharma AG, Sanquin, Laboratoire Franais du Fractionnement et des Biotechnologies, Kedrion, and Biotest. Partnerships, collaborations, mergers & acquisitions, agreements, expansions, joint ventures, and others are some of the key strategies adopted by these prominent manufacturers to strengthen their position in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
The Plasma Fractionation Market By Product
The Plasma Fractionation Market By Application
The Plasma Fractionation Market By End User
The Plasma Fractionation Market By Geography
Key Market Players:
About Intense Research
Intense Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Intense Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
GMT Tel: +49-322 210 92714
USA/Canada Toll No. 1-855-465-4651